Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02613650
Recruitment Status : Recruiting
First Posted : November 24, 2015
Last Update Posted : November 3, 2021
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
University of Utah

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022